Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Men with enlarged prostates often have more severe baldness.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Testosterone significantly affects urination differences between male and female mice.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

A new compound was effective for imaging prostate cancer in rats.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

A 90-year-old man was diagnosed with heart failure due to wild-type transthyretin cardiac amyloidosis.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.